MARSEILLE, France, March 17, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, today announces that the Company will host a Research and Development Update on April 10, 2014, in New York, from 8am to 1pm.
Help employers find you! Check out all the jobs and post your resume.
